“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2017 ended on 30 June 2017 which were reviewed by the auditor. The Company hereby
“Company”) submitted its separate financial statement and its consolidated financial statement for the first quarter of 2020 ended on 31 March 2020 which were reviewed by the auditor. The Company hereby
the one- time expense, normalized EBITDA in 2Q19 was Bt19,753mn, increasing 4% YoY and 4. 5% QoQ, while normalized net profit was Bt8,234mn, increasing 2.9% YoY and 8. 1% QoQ. In conclusion for 1H19
(Taixing) Limited (“SBT”). Moreover, it was also caused by the transitional service expense plus the additional transportation and commission costs. * Note Please find further information in the consolidated
Public Company Limited (“the Company”) would like to report on Management Discussion and Analysis from the Separate and Consolidated Financial Statements of the year ended December 31, 2017. The details
Company Limited (“the Company”) would like to report on Management Discussion and Analysis from the Separate and Consolidated Financial Statements of the 1st quarter ended March 31, 2018. The details are as
Ventures Public Company Limited for the first quarter of 2018 We are pleased to submit: 1. Consolidated and Company only Annual Audited Financial Statements for the first quarter of 2018 (a copy in Thai and
by an auditor as follows: Unit : Million Baht CONSOLIDATED FINANCIAL STATEMENTS For the three-month periods ended September 30, Continuing operations Discontinued operation Total 2019 2018 2019 2018
” or “we” or “our” or “us”) would like to inform management discussion and analysis for its results of operations from the consolidated financial statements for the three months period ended March 31
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and